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Abstract
α-Conotoxins inhibit nicotinic acetylcholine receptors (nAChRs) and are used as probes to study
cholinergic pathways in vertebrates. Model organisms, such as Drosophila melanogaster, express
nAChRs in their CNS that are suitable to investigate the neuropharmacology of α-conotoxins in vivo. Here
we report the paired nanoinjection of native α-conotoxin PIA and two novel α-conotoxins, PIC and PIC[O7],
from the injected venom of Conus purpurascens and electrophysiological recordings of their effects on
the giant fiber system (GFS) of D. melanogaster and heterologously expressed nAChRs in Xenopus
oocytes. α-PIA caused disruption of the function of giant fiber dorsal longitudinal muscle (GF-DLM)
pathway by inhibiting the Dα7 nAChR a homolog to the vertebrate α7 nAChR, whereas PIC and PIC[O7] did
not. PIC and PIC[O7] reversibly inhibited ACh-evoked currents mediated by vertebrate rodent (r)α1β1δγ,
rα1β1δε and human (h)α3β2, but not hα7 nAChR subtypes expressed in Xenopus oocytes with the
following selectivity: rα1β1δε > rα1β1δγ ≈ hα3β2 > > hα7. Our study emphasizes the importance of loop
size and α-conotoxin sequence specificity for receptor binding. These studies can be used for the
evaluation of the neuropharmacology of novel α-conotoxins that can be utilized as molecular probes for
diseases such as, Alzheimer's, Parkinson's, and cancer.
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ABSTRACT: α-Conotoxins inhibit nicotinic acetylcholine receptors (nAChRs) and are used as
probes to study cholinergic pathways in vertebrates. Model organisms, such as Drosophila
melanogaster, express nAChRs in their CNS that are suitable to investigate the
neuropharmacology of α-conotoxins in vivo. Here we report the paired nanoinjection of native
α-conotoxin PIA and two novel α-conotoxins, PIC and PIC[O7], from the injected venom of
Conus purpurascens and electrophysiological recordings of their effects on the giant fiber
system (GFS) of D. melanogaster and heterologously expressed nAChRs in Xenopus oocytes. αPIA caused disruption of the function of giant fiber dorsal longitudinal muscle (GF-DLM)
pathway by inhibiting the Dα7 nAChR a homolog to the vertebrate α7 nAChR, whereas PIC and
PIC[O7] did not. PIC and PIC[O7] inhibited ACh-evoked currents mediated by vertebrate rodent
(r)α1β1δγ, rα1β1δε and human (h)α3β2, but not hα7 nAChR subtypes expressed in Xenopus
oocytes with the following selectivity: rα1β1δε > rα1β1δγ ≈ hα3β2 >> hα7. Our study
emphasizes the importance of loop size and α-conotoxin sequence specificity for receptor
binding. These studies can be used for the evaluation of the neuropharmacology of novel αconotoxins that can be utilize as molecular probes for diseases such as, Alzheimer’s,
Parkinson’s, and cancer.
KEYWORDS: venom, cone snails, α-conotoxins, nAChRs, giant fiber system, Drosophila, oocytes
ABBREVIATIONS: HPLC, high performance liquid chromatography; GF, giant fiber; GFS, giant
fiber system; DLM, dorsal longitudinal muscle; nAChR, nicotinic acetylcholine receptor

1. INTRODUCTION
Predatory marine mollusks of the genus Conus (cone snails) produce a potent and complex
venom, largely composed of highly modified peptides (conopeptides and conotoxins) that
interact with a variety of molecular targets within their prey such as, K+ channels, Na+ channels,
Ca2+ channels, and nicotinic acetylcholine receptors (nAChRs), among others (Akondi et al.,
2014; Lewis et al., 2012; Marí and Tytgat, 2010). The venom of each Conus species contains
over 2,000 unique conopeptides spanning over 30 conotoxin gene superfamilies (Biass et al.,
2009; Robinson and Norton, 2014). There are seven classes of conotoxins that target nAChRs
(Lebbe et al., 2014). However, α-conotoxins are the quintessential nAChR inhibitors found in
the venom of most species of cone snails (Akondi et al., 2014). These peptides are 12-19 amino
acids in length with two loops formed by the cysteine arrangement of C1-C3 and C2-C4 forming
disulfide bonds (McIntosh et al., 1999). Several α-conotoxins are used as molecular probes to
inhibit nAChRs with preferential inhibition towards specific subtypes depending upon the αconotoxin in question (Cuny et al., 2017; Heghinian et al., 2015). Such specificity has greatly
advanced our knowledge of cholinergic-mediated mechanisms of neurological conditions such
as Alzheimer’s disease, schizophrenia, nicotine addiction, and depression disorders (Taly and
Charon, 2012; Valles and Barrantes, 2012; Quik et al., 2015). One α-conotoxin, Vc1.1, has
reached phase IIA clinical trials as a neuropathic pain therapeutic (Castro et al., 2017; Livett et
al., 2006).
The fruit fly is an ideal model organism for studying conotoxins due to the small amounts of
venom necessary to elicit responses and the extensive number of studies that have been
carried out on the neurobiology of these flies. We have previously described a novel bioassay to
characterize conotoxins by pairing the in vivo nanoinjection of the conotoxins with
simultaneous collection of electrophysiological recordings from the Drosophila melanogaster
giant fiber system (GFS) (Mejia et al., 2010; Mejia et al., 2012). The GFS is a well-characterized
neuronal circuit responsible for the mediation of the fly’s escape response. The circuit
terminating on two muscles, the Dorsal Longitudinal Muscle (DLM) and the Tergo Trochanteral
Muscle (TTM), contains three types of neurons with respect to synaptic transmission. The Giant
Fiber (GF) innervates the Tergo Trochanteral Motor neuron (TTMn) and the Peripheral
Synapsing Interneuron (PSI) via mixed electrical and cholinergic chemical synapses but the
connections are predominantly dependent on gap junctions. In contrast, the synapse between
the PSI and Dorsal Longitudinal Motor neuron (DLMn) is solely dependent upon the Drosophila
α7 nAChR (Heghininan et al., 2015), a homolog of the human α7 nAChR (Fayyazuddin et al.,
2006), whereas the motor neurons use glutamate as a neurotransmitter.
We have previously demonstrated selective disruption of the GF-DLM but not the TTM pathway
by several α-conotoxins from different Conus species confirming that this assay is an effective

and specific screening method for α-conotoxins (Mejia et al., 2013). Here we report the
isolation of one known α-conotoxin (PIA) and two novel α-conotoxins (PIC and PIC[O7]) and
their direct in vivo characterization in the D. melanogaster GFS. We also determined the activity
of PIC and PIC[O7] at rodent and human nAChR subtypes and PIA at human 7 nAChRs
expressed in Xenopus laevis oocytes. All three α-conotoxins were isolated from the injected
venom of Conus purpurascens, the only fish-hunting cone snail species found in the tropical
Eastern Pacific region. The α-conotoxins of C. purpurascens act synergistically with other
paralytic components (the motor cabal) to produce a flaccid paralysis as part of the mechanism
of envenomation used to secure the prey. The disruption of cholinergic pathways is central to
the mechanism of envenomation used by cone snails. Their associated neuropharmacology is
still unraveling.

2. METHODS AND MATERIALS
2.1 Conotoxin extraction
The injected venom was “milked” from a single live C. purpurascens individual using the
protocol established previously (Hopkins et al., 1995). Briefly, the snail was enticed with a
feeder gold fish until the proboscis was extended, and then the fish was replaced with a “trap”
made from a microcentrifuge tube with the opening covered in latex and a fish tail. The snail
was able to sense the fish tail and sting the trap, injecting its venom into the microcentrifuge
tube. The care and maintenance of the gold fish followed the Institutional Animal Care and Use
Committee (IACUC) guidelines established at Florida Atlantic University. The injected venom
was collected once a week with an average volume of 10 μL and stored at 80°C until needed.
2.2 Isolation of Conotoxins by RP-HPLC
PIA, PIC, and PIC[O7] were isolated by RP-HPLC from the injected venom of a single C.
purpurascens individual (Figure 1) by pooling the venom from several “milkings” to obtain a
total volume of 50 μL. The venom was then diluted with 0.1% TFA (trifluoroacetic acid) in
preparation for RP-HPLC analysis by a Series 200 LC pump (Perkin Elmer, Waltham, MA, USA)
coupled to a SpectroMonitor 5000 Photodiode Array Detector (LDC Inc., Carlsbad, CA, USA).
Venom was separated on a 4.6 mm x 50 mm, 2.6 μm-particle diameter, 100 Å-pore size Kinetex
C8 column (Phenomenex, Torrance, CA, USA) using an incremental linear gradient of 100%
solution A (0.1% TFA, 99.9% H2O) to 100% solution B (60% acetonitrile in 0.1% TFA) over 100
min with a flow rate of 1.0 mL/min. Chromatography was monitored using PeakSimple 4.35
system (SRI Instruments, Torrance, CA, USA). Fractions were manually collected under UV
monitoring at λ = 205, 220, and 280 nm. Fractions were dried and stored at -20°C until needed.

The molecular masses of the conotoxins were determined by MALDI-TOF MS, Applied
Biosystems Voyager-DE PRO mass spectrometer (Framingham, MA, USA) (Table 1)(Rodriguez et
al., 2015).
2.3 Conotoxin Sequencing by Edman degradation
An aliquot corresponding to PIC and PIC[O7] fractions were dried, re-dissolved in 0.1 M Tris-HCl
(pH 6.2), 5 mM EDTA, and 0.1 % sodium azide, and reduced with 6 mM dithiothreitol. Following
incubation at 60 °C for 30 min, the sample was alkylated in a final volume of 15 μL with 20 mM
iodoacetamide and 2 μl of NH4OH (pH 10.5) at room temperature (20-24C) for 1 h in the dark.
The reduced/alkylated peptides were dried and re-dissolved in 15 μL of water for sequencing by
Edman degradation on an Applied Biosystems Procise model 491A sequencer.
2.4 In vivo Electrophysiology in the Drosophila melanogaster Giant Fiber
The paired method of electrophysiology and nanoinjection in D. melanogaster has been
described previously (Mejia et al., 2012; Mejia et al., 2013). Briefly, wild-type flies (w1118, fly
stocks #3605 obtained from the Bloomington Drosophila Stock Center) were kept at 25°C in
vials with standard media. The α-conotoxins were prepared in 0.7% saline to a final
concentration that allowed for the desired pmol of peptide to be injected. α-Conotoxins PIA,
PIC, and PIC[O7] were injected at various concentrations into the hemolymph of the fly while
simultaneously recording from the GFS. Control flies were injected with 0.7% saline solution
without peptide. The GFs were stimulated in the brain with 10 trains of 10 stimuli given at 100
Hz with 1 s intervals between trains and the GF-DLM and GF-TTM pathways were monitored for
changes in the following frequency (FF). Muscle response was monitored before and 1, 5, 10,
15, and 20 min after injection (n = 10 for all experiments). Sigma Plot (Systat Software, San Jose,
CA, USA) was used to perform the statistical analysis using a nonparametric Kruskal-Wallis 1way ANOVA and Tukey test.
2.5 In vitro Electrophysiology in Xenopus oocytes expressing nAChRs
Oocyte preparation and nAChR subunit expression in Xenopus oocytes were performed as
described previously (Heghinian et al., 2015). Briefly, plasmids with cDNA encoding the rat (α1,
β1, γ and δ), mouse (ε) and human (α7, α3 and β2) nAChR subunits were linearized for in vitro
mRNA synthesis using mMESSAGE mMACHINE kit (Ambion, Foster City, CA, USA). Oocytes were
injected with 5 ng cRNA two to five days before recording and kept at 18 °C in ND96 buffer (96
mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2 and 5 mM HEPES, at pH 7.4) supplemented with
5% fetal bovine serum (Bovogen Biologicals, East Keilor, VIC, Australia), 50 mg/L gentamycin
(GIBCO, Grand Island, NY, USA) and 10,000 U/mL penicillin-streptomycin (GIBCO, Grand Island,
NY, USA). Voltage-recording and current-injecting microelectrodes were pulled from GC150T-

7.5 borosilicate glass (Harvard Apparatus Ltd., Holliston, MA, USA) giving tip resistances of 0.3–
1.5 MΩ when filled with 3 M KCl. Two-electrode voltage clamp recordings from oocytes were
conducted at room temperature (22-23C) using a GeneClamp 500B amplifier, Digidata 1322A
interface and pClamp 9 software (Molecular Devices, Sunnyvale, CA, USA) at a holding potential
of 80 mV.
Initially, oocytes in a 10 µL recording chamber were continuously perfused with ND96 solution
at 2 ml/min, applied by a pump perfusion system. nAChR-mediated currents were evoked by
applications of acetylcholine (ACh) at half-maximal effective concentration (EC50) of 1 μM for
rodent muscle, 6 μM for hα3β2 and 100 μM for hα7 nAChRs . Oocytes were preincubated with
peptide for 5 min with the perfusion system turned off, followed by co-application of ACh and
peptide with flowing bath solution. Washout with bath solution occurred for 3 min between
ACh applications. All peptide solutions were prepared in ND96 + 0.1% bovine serum albumin.
Peak ACh-evoked current amplitudes before (ACh alone) and after (ACh + peptide) peptide
incubation were measured using Clampfit version 10.7.0.3 software (Molecular Devices,
Sunnyvale, CA, USA), where the ratio of ACh + peptide-evoked current amplitude to ACh aloneevoked current amplitude was used to assess the activity of PIA, PIC and PIC[O7] on AChevoked currents. All electrophysiological data were pooled and represent means ± standard
error of the mean (SEM). Data sets were compared using an unpaired Student’s t-test
(GraphPad Prism 7, GraphPad Software, La Jolla, CA, USA). Differences were regarded statistically
significant when p < 0.05.
2.6 Homology Modeling of PIA Bound to the Dα7 nAChR Receptor
Homology modeling of PIA and PIC bound to the Dα7 nAChR were done with Modeler v9.18
(Webb and Sali, 2014) using a method described previously (Heghinian et al., 2015). Briefly, the
X-ray crystal structure of Aplysia californica acetylcholine binding protein (AChBP) bound to conotoxin ImI (PDB ID: 2C9T) was used as a binding template (Ulens et al., 2006). Chimera v.6.1
was used for the molecular graphics analysis (Yang et al., 2012).
2.7 Transcriptome of the C. purpurascens venom duct
RNA was extracted from freshly dissected venom duct tissue and prepared utilizing the Illumina
PolyA-Truseq preparation protocol. Samples were then sequenced on a Next-Seq 500 Illumina
sequencing platform to produce four sets of paired end sequences. All runs were concatenated
to produce two single independent datasets containing 31 million forward and reverse reads.
Quality metrics were obtained using FASTQC and read distribution statistics were calculated
with BBMap to prove accurate group fragment pair distance (141 bp) for read assembly. The
paired-end data was then assembled using De-Bruijn graph based De Novo assembler, Trinity
(Grabherr et al., 2011), to produce a final FASTA dataset containing 64321 independent

assembled contigs. Final assembled contigs were then converted to a BLAST database using
NCBI Blast+ and full protein sequences were identified using local NCBI BLASTx with an e-value
cutoff of e-7.
3. RESULTS
3.1 Isolation and Sequencing of PIA, PIC and PIC[O7]
The RP-HPLC profile of the injected venom from a single individual of C. purpurascens is shown
in Figure 1. The peaks eluted at 17 (PIC[O7]), 19 (PIC) and 57 (PIA) min were collected and
MALDI-TOF mass spectrometry of the purified RP-HPLC fraction in reflector mode yielded
molecular mass of 1460.13, 1475.11and 1980.94 Da, respectively (Table 1). The theoretical
molecular mass of PIA is 1732.42 Da. The fractions that eluted at 17 and 19 min were reduced
and alkylated and sequenced using Edman degradation yielding the sequences of the novel
α4/4-conotoxins PIC and PIC[O7], respectively. The transcriptome of C. purpurascens venom
revealed the presence of the precursor sequence for PIC and PIC[O7], whose signal sequence
corresponds to the A-superfamily of conotoxins (Table 1S).

Figure 1

3.2 In vivo Electrophysiology Responses of PIA, PIC and PIC[O7] in the Drosophila melanogaster
Giant Fiber
α-Conotoxins PIA had an inhibitory effect on the GF-DLM pathway (Figure 2A and 2B, n = 10).
PIA displayed the most significant disruption of the GF-DLM responses at 88 pmol/fly (Figure
2A) compared to the 0.7% saline control injection while having no effect on the GF-TTM
pathway (Figure 1S). At this concentration, α-PIA decreases the probability of DLM responses to
9.8 ± 4.4% and 4.2 ± 0.2% at 10 and 20 min post injection, respectively. To determine the
effects of α-PIA at lower concentrations, 67, 44, and 21 pmol of PIA/fly were injected as well,
which caused a reduced dose-dependent inhibition of the GF-DLM pathway. At the lowest
concentration tested, the DLM response probability was reduced to 67.7 ± 11.8% by 10 min and
47.0 ± 8.0% by 20 min post injection.
PIC caused less inhibition of the GF-DLM pathway at 88 pmol/fly than PIA. Although PIC caused
the DLM response to decreased to 69.5 ± 16.5% after 20 min post-injection when compared to
the 0.7% saline control, an ANOVA analysis followed by a Tukey test showed that these
measurements were not statistically significant when compared to the control. PIC[O7] at a
concentration of 88 pmol/fly, exhibited no significant inhibition of the DLM response

probability. Similar to α-PIA, the GF-TTM pathway was unaffected by both, PIC and PIC[O7]
(Figure 1S).

Figure 2

3.3 In vitro Electrophysiology Activity of PIC and PIC[O7] at Heterologously Expressed nAChRs in
Xenopus Oocytes
α-Conotoxins PIC and PIC[O7] were tested at vertebrate human (h)α3β2, hα7, rodent
(r)α1β1δγ, and rα1β1δε nAChR subtypes. PIA was tested at the hα7 nAChR using ImI as a
positive control. We investigated the effects of the -conotoxins on ACh-evoked currents
mediated by nAChR subunit combinations expressed in Xenopus oocytes (Figure 3A and B). At 1
µM, α-conotoxins PIC and PIC[O7] reversibly inhibited ACh-evoked currents mediated by
rα1β1δε nAChR by 59.8 ± 7.7% and 64.1 ± 4.6% (n = 3), respectively. Both conotoxins also
inhibited the hα3β2 and rα1β1γδ nAChR subtypes by ~30-45% whereas, only minimal inhibition
(<10%) was observed at the hα7 nAChR subtype. At 1 µM, α-conotoxin PIA reversibly inhibited
hα7 mediated ACh-evoked currents by <5% (n = 4), whereas, α-conotoxin ImI, used as a
positive control on the same oocytes and at the same concentration, reversibly inhibited >80%
(82.7 ± 2.2%, n = 4) of ACh-evoked current amplitude. In summary, PIC and PIC[O7] inhibited
the muscle and neuronal nAChRs with the following selectivity sequence: rα1β1δε > rα1β1δγ ≈
hα3β2 >> hα7 (Table 1). Surprisingly, PIC[O7] caused a slightly greater inhibition of rα1β1δε
and rα1β1δγ than PIC.
Figure 3

3.4 Molecular Interactions of PIA and PIC at the Dα7 nAChR
The interactions between PIA, PIC and the Dα7 nAChR were further rationalized by homology
modeling based upon the crystal structure of Aplysia californica AChBP bound to α-conotoxin
ImI (Brejc et al., 2001; Ulens et al., 2006), a suitable surrogate to study nAChR-conotoxin
interactions. The key residues of PIA that determine binding to Dα7 nAChR are predicted to be
Asn7 and Val9 at the Dα7 principal side, and Ser6 and Val12 at the Dα7 complementary side of
the binding pocket. These residues are predicted to bind to the receptor primarily through
hydrogen bonding (Figure 4A, red) and hydrophobic interactions (Figure 4A, orange). This
model predicts that PIA (yellow) is essentially ‘glued’ to the interfaces of Dα7 at the C-loop of
the principal side (Figure 4A, light blue) and binding pocket of the complementary side (Figure
4A, dark blue). The homology model of PIC and Dα7 predicts fewer conotoxin-receptor

interactions (Fig. 4B), only one interaction with the C-loop of the principal side through R13 in
PIC. Additional residues of PIC that determine binding to Dα7 are predicted to be Pro7 at the
Dα7 principal side, and Lys11 at the Dα7 complementary side of the binding pocket.

Figure 4

4. DISCUSSION
The injected predatory venom of cone snails is a complex mixture of components that act
synergistically to immobilize the prey. The functional characterization of such components is a
major challenge, as these components are expressed in minute quantities and their direct
neuropharmacological assessment, especially when using in vivo assays, is typically
unreachable. Nevertheless, we have devised a Drosophila-based in vivo assay that permits the
evaluation of picomole venom quantities. This assay is particularly suitable for the
characterization of α-conotoxins, as the GF-DLM pathway (flight response) and not the GF-TTM
(jump response) will be affected by α-conotoxins. Interestingly, not all α-conotoxins affect the
Drosophila α7 nAChR in the same manner, as we have recently demonstrated for a panel of αconotoxins from different species (Heghinian et al., 2015; Mejia et al., 2010; Mejia et al., 2013).
Cone snails express a variety of α-conotoxins that in turn have can have differential inhibition
profiles for the nAChRs present in the prey. The particular individual of C. purpurascens
analyzed here expresses the known α4/7-conotoxin PIA and two new ones, PIC and its
hydroxylated analog PIC[O7]. PIC and PIC[O7] are α4/4-conotoxins with four amino acid
residues between each cysteine loop. This is the same cysteine loop arrangement as PIB (Table
1), a known inhibitor of muscle-subtype nAChRs located at the mammalian neuromuscular
junction (Lopez-Vera et al., 2007). -PIB was not expressed in the venom of this individual and
was not tested. Sequence homology suggests that α-PIC and α-PIC[O7] may have similar
selectivity to nAChRs as PIB.
Testing of the α4/4-conotoxins PIC and PIC[O7] at nAChR subtypes expressed in Xenopus
oocytes showed that these conotoxins preferentially inhibit the rodent muscle nAChRs more
than the human neuronal nAChR subtypes (see Fig. 3). This explains the lack of PIC and PIC[O7]
activity at the neuronal nAChRs compared to α-PIA, a known neuronal nAChR subtype inhibitor.
The Dα7 nAChR is a “neuronal-like” subtype, most similar to the mammalian α7 subtype
(Heghinian et al., 2015). However, Dα7 has been sensitive to most α-conotoxins tested to date.

These two lineages of α-conotoxins from the venom of C. purpurascens with varying activity
between neuronal and neuromuscular nAChRs may partially explain the lower potency of PIC
for the Dα7 nAChR when compared to PIA. PIA is a α4/7-conotoxin with low sequence
homology to the 4/4 counterparts and the longer second loop may be the cause of the
difference in selectivity towards the Dα7 nAChR (Cuny et al., 2016). Synthetic α-PIA does not
inhibit human α1β1δε and it has low selectivity towards rat α3β2 nAChRs when compared to
α6β2β3 (Dowell et al., 2003). In this study, we show that native PIA was inactive at the human
7 nAChR. Synthetic conotoxins may exhibit different folding patterns and posttranslational
modifications from the native peptide, which could account for differences in sensitivity and
activity (Kang et al., 2007; Khoo et al., 2012). It is important to note that in this study we
evaluate the in vivo activity of conotoxins, which may differ from their activity in single cells.
The nAChR C-loop is essential in linking the conformational changes that occur when the
endogenous acetylcholine ligand binds to the receptor to the open the pore. Homology models
of the complex between Dα7 and PIA predict multiple interactions at the principal and
complementary binding sites that resulted in locking the C-loop in a resting position hindering
ACh binding and hampering the conformational changes needed for the channel to open (Celie
et al., 2005). As a result, synaptic transmission is inhibited leading to reduced DLM response. In
contrast, the model of complex between Dα7 and PIC showed diminished interactions between
PIC and the C-loop, which is consistent with PIC non-inhibitory activity when compared to PIA.
While these models provide a rational for such interactions, the precise interaction of
conotoxins with nAChRs can vary depending on the specific nAChR subtype and specific
conotoxin in consideration.
This study accounts for the efficacious application of the GFS assay, where injected venom
components of C. purpurascens were used to complete the in vivo assay. Here we have
described the isolation of picomole quantities α-conotoxins PIA, PIC, and PIC[O7] from the
injected venom of a single individual of C. purpurascens and the corresponding in vivo
functional characterization in a Drosophila-based functional assay that involves the Dα7 nAChR
subtype. PIA is a known selective α6β2β3 and to a lesser extent a α3β2 nAChR inhibitor, but we
have shown that PIA also inhibits the Dα7 nAChR. We have also shown that the novel conotoxin PIC and its hydroxylated counterpart PIC[O7] have no significant inhibitory activity at
Dα7 nAChRs. At rα1β1δε and rα1β1γδ nAChRs, PIC[O7] is a slightly more potent inhibitor than
PIC suggesting that proline hydroxylation plays a delicate role in the mechanism of nAChR
inhibition by α-conotoxins (Franco & Mari, 2005).
We have demonstrated that the Drosophila-based in vivo assay can be used to functionally
characterize minute quantities of α-conotoxins. These findings can be readily correlated with
vertebrate cholinergic pathways (Heghinian et al., 2015; Thany et al., 2007). The GFS assay is an

effective tool for in vivo screening of α-conotoxins, with the advantage of using picomole
quantities of the native natural product inhibitors. Furthermore, future studies can be
envisioned through genetic manipulations of the Dα7 nAChR, allowing structure-activity
relationship studies for α-conotoxins and nAChR subtypes, which ultimately can be used for the
evaluation of the neuropharmacology of novel α-conotoxins that can be utilize as molecular
probes for diseases such as Alzheimer’s, Parkinson’s, and cancer.
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Table 1. Sequences and nAChR selectivity of α-conotoxins from the venom of C. purpurascens.
Conotoxin

Sequence

Molecular
mass (Da)
1980.94

PIA ( Dowell et al.,
2003)

RDPCCSNPVCTVHNPQIC*

nAChR selectivitya
rα6/α3β2  rα6/α3β2β3 >
rα6/α3β4 > rα3β2 > rα3β4 >>
rα4β2, rα4β4
hα6/α3β2β3 > hα6/α3β4 >>
hα1β1

PIB (Lopez-Vera et al.,
2007)

ZSOGCCWNPAC-VKNR--C*

PIC

SGCCKHPAC-GKNR--C

PIC[O7]

SGCCKHOAC-GKNR--C

(not in this
study)

rα1β1δε, rα1β1γδ >> rα3β2,
rα3β4, rα7

1460.13

rα1β1δε > rα1β1δγ ≈ hα3β2
>> hα7

1475.11

rα1β1δε > rα1β1δγ ≈ hα3β2
>> hα7

* indicates an amidated C-terminus, Z indicates pyroglutamate, O indicates hydroxyproline.ar = rodent, h
= human

Figure 1. Isolation of PIA, PIC, and PIC[O7] by reversed-phase HPLC of the injected venom of a single
individual of C. purpurascens.
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Figure 2 . Functional characterization of α-conotoxins PIA, PIC, and PIC[O7] in picomoles/fly in the D.
melanogaster giant fiber system (GFS). (A) Effect of PIA at different concentrations on the following
frequency (FF) of the GF-DLM pathway. (B) Effect of PIC and PIC[O7] on the FF of the GF-DLM pathway
(mean ± SEM, n = 10, * p < 0.05)

A

B

Figure 3. Activity of PIC and PIC[O7] at rodent and human nAChR subtypes. A) Superimposed
representative ACh-evoked currents recorded from X. laevis oocytes expressing rodent (r)α1β1δε and
human (h)α7 nAChRs in the absence (control, black trace) and presence (red trace) of 1 µM PIC or 1 µM
PIC[O7]. B) Bar graph of PIC and PIC[O7] (1 µM) inhibition of ACh-evoked peak current amplitude
mediated by rα1β1δε, rα1β1δγ, hα3β2 and hα7 subtypes (mean ± SEM, n = 3, * p < 0.05, ** p < 0.0001).

Figure 4. A. PIA (yellow) bound at the interface of the principal (light blue) and complementary (dark
blue) Dα7 subunits. Inset: Position of PIA/PIC (yellow) bound between Dα7 subunits B. PIA is complexed
to the binding pocket via hydrogen bond interactions between residues S6, V12 and C17 (red) with the
principal binding side and hydrophobic interactions between residues N7 and V9 (orange) with the Cloop of the complementary side. V12 is involved in hydrogen bonding and hydrophobic interactions. C.
PIC (green) bound at the interface of the principal (light blue) and complementary (dark blue) Dα7
subunits. D. PIC is complexed to the binding pocket via a single hydrogen bond interactions between
residue R13 (red) with the principal binding site and hydrophobic interactions between residue K11
(orange) with the complementary side and P7 (orange) with the principal binding side.

